🔴 Picard Medical is trading 10.18% down in after-hours trading; no confirmed catalyst identified

Picard Medical is trading 10.18% down at $8.56 after an exceptionally volatile August 25, 2026 session; no confirmed catalyst directly explains the after-hours decline.

• The session closed at $9.53 after consecutive gains of 59.81% and 85.77%.
• Q2 revenue was approximately $2.95 million versus $1.55 million expected, while the $3.05-per-share loss missed the $1.50 estimate.
• Coverage explains the earlier surge, but no catalyst has been confirmed for the decline.